Matthew Harrison Initiated (BIIB) at Buy and Held Target at $395 on, Mar 27th, 2014

Health and Fitness Health and Fitness

^{Published on 2024-10-25 04:29:55 - WOPRAI, Matthew Harrison}

Matthew Harrison of Morgan Stanley, Initiated "Biogen Inc." (BIIB) at Buy and Held Target at $395 on, Mar 27th, 2014.

Matthew has made no other calls on BIIB in the last 4 months.

There are 3 other peers that have a rating on BIIB. Out of the 3 peers that are also analyzing BIIB, 0 agree with Matthew's Rating of Hold.

These are the ratings of the 3 analyists that currently disagree with Matthew

Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $400 on, Friday, February 14th, 2014
Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $415 on, Tuesday, January 28th, 2014
Christopher Marai of "Nomura" Initiated at Strong Buy and Held Target at $368 on, Wednesday, January 8th, 2014

Similar Health and Fitness Articles

[ Fri, Feb 14th 2014 ] - WOPRAI

[ Tue, Jan 28th 2014 ] - WOPRAI

[ Wed, Jan 08th 2014 ] - WOPRAI

[ Tue, Nov 26th 2013 ] - WOPRAI

[ Mon, Apr 22nd 2013 ] - WOPRAI

[ Tue, Apr 09th 2013 ] - WOPRAI